RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
KMPharmaceutical Co Stock

KMPharmaceutical Co Equity 2024

KMPharmaceutical Co Equity

35.48 B KRW

Ticker

225430.KQ

ISIN

KR7225430008

In 2024, KMPharmaceutical Co's equity was 35.48 B KRW, a -2.34% increase from the 36.33 B KRW equity in the previous year.

KMPharmaceutical Co Aktienanalyse

What does KMPharmaceutical Co do?

KMPharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing KMPharmaceutical Co's Equity

KMPharmaceutical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding KMPharmaceutical Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating KMPharmaceutical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

KMPharmaceutical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in KMPharmaceutical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about KMPharmaceutical Co stock

What is the equity of KMPharmaceutical Co this year?

KMPharmaceutical Co has equity of 35.48 B KRW this year.

What was the equity of KMPharmaceutical Co compared to the previous year?

The equity of KMPharmaceutical Co has increased/decreased by -2.34% decreased compared to the previous year.

What impact does a high equity have on investors of KMPharmaceutical Co?

A high equity is advantageous for investors of KMPharmaceutical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of KMPharmaceutical Co?

A low equity can be a risk for investors of KMPharmaceutical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of KMPharmaceutical Co affect the company?

An increase in equity of KMPharmaceutical Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of KMPharmaceutical Co affect the company?

A reduction in equity of KMPharmaceutical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of KMPharmaceutical Co?

Some factors that can affect the equity of KMPharmaceutical Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of KMPharmaceutical Co so important for investors?

The equity of KMPharmaceutical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can KMPharmaceutical Co take to change the equity?

To change equity, KMPharmaceutical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does KMPharmaceutical Co pay?

Over the past 12 months, KMPharmaceutical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, KMPharmaceutical Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of KMPharmaceutical Co?

The current dividend yield of KMPharmaceutical Co is .

When does KMPharmaceutical Co pay dividends?

KMPharmaceutical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of KMPharmaceutical Co?

KMPharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of KMPharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is KMPharmaceutical Co located?

KMPharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von KMPharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of KMPharmaceutical Co from 12/19/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.

When did KMPharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of KMPharmaceutical Co in the year 2023?

In the year 2023, KMPharmaceutical Co distributed 0 KRW as dividends.

In which currency does KMPharmaceutical Co pay out the dividend?

The dividends of KMPharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von KMPharmaceutical Co

Our stock analysis for KMPharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KMPharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.